The missing piece in post-transplant bone health: tertiary hyperparathyroidism management.
作者信息
Helvacı Burçak Cavnar, Helvacı Özant
机构信息
Department of Endocrinology and Metabolism, Ankara Etlik City Hospital, Ankara, Turkey.
Department of Nephrology, Gazi University Faculty of Medicine, Bes¸evler, Ankara 06500, Turkey.
出版信息
Ther Adv Endocrinol Metab. 2025 Jul 18;16:20420188251359790. doi: 10.1177/20420188251359790. eCollection 2025.
Abstract
摘要
相似文献
1
The missing piece in post-transplant bone health: tertiary hyperparathyroidism management.移植后骨骼健康中缺失的环节：三发性甲状旁腺功能亢进的管理。
Ther Adv Endocrinol Metab. 2025 Jul 18;16:20420188251359790. doi: 10.1177/20420188251359790. eCollection 2025.
2
Outcome of surgical parathyroidectomy for tertiary hyperparathyroidism in kidney transplant recipients: tertiary hyperparathyroidism should not be ignored, for the sake of precious allografts.肾移植受者甲状旁腺切除术治疗三发性甲状旁腺功能亢进症的结果：为了珍贵的同种异体移植物，三发性甲状旁腺功能亢进症不应被忽视。
Ren Fail. 2024 Dec;46(1):2333919. doi: 10.1080/0886022X.2024.2333919. Epub 2024 Apr 4.
3
Calcimimetics or parathyroidectomy for kidney transplant recipients: is there still a question? a systematic review, meta-analysis and trial sequential analysis.拟钙剂或甲状旁腺切除术用于肾移植受者：还有疑问吗？一项系统评价、荟萃分析和试验序贯分析
Endocrine. 2025 Feb 8. doi: 10.1007/s12020-025-04189-9.
4
Machine Learning-Derived Integer-Based Score and Prediction of Tertiary Hyperparathyroidism among Kidney Transplant Recipients: An Integer-Based Score to Predict Tertiary Hyperparathyroidism.机器学习衍生的整数基评分与肾移植受者甲状旁腺功能亢进症的预测：一种预测甲状旁腺功能亢进症的整数基评分。
Clin J Am Soc Nephrol. 2022 Jul;17(7):1026-1035. doi: 10.2215/CJN.15921221. Epub 2022 Jun 10.
5
Timing of parathyroidectomy for tertiary hyperparathyroidism with end-stage renal disease: A cost-effectiveness analysis.甲状旁腺切除术治疗终末期肾病继发甲状旁腺功能亢进症的时机：成本效益分析。
Surgery. 2021 Jan;169(1):94-101. doi: 10.1016/j.surg.2020.06.012. Epub 2020 Jul 27.
6
Impact of parathyroidectomy on kidney graft function in post-transplant tertiary hyperparathyroidism: a comparative study.甲状旁腺切除术对移植后甲状旁腺功能亢进症患者移植肾功能的影响：一项对比研究。
Langenbecks Arch Surg. 2022 Sep;407(6):2489-2498. doi: 10.1007/s00423-022-02555-z. Epub 2022 May 21.
7
Management of Post-transplant Hyperparathyroidism and Bone Disease.移植后甲状旁腺功能亢进和骨病的管理。
Drugs. 2019 Apr;79(5):501-513. doi: 10.1007/s40265-019-01074-4.
8
A roadmap to parathyroidectomy for kidney transplant candidates.肾移植候选者甲状旁腺切除术路线图
Clin Kidney J. 2022 Feb 23;15(8):1459-1474. doi: 10.1093/ckj/sfac050. eCollection 2022 Aug.
9
Pre-Transplant Calcimimetic Use and Dose Information Improves the Accuracy of Prediction of Tertiary Hyperparathyroidism after Kidney Transplantation: A Retrospective Cohort Study.移植前使用拟钙剂和剂量信息可提高肾移植后甲状旁腺功能亢进症预测的准确性：一项回顾性队列研究。
Transpl Int. 2024 May 1;37:12704. doi: 10.3389/ti.2024.12704. eCollection 2024.
10
Timing of parathyroidectomy for tertiary hyperparathyroidism after kidney transplant.肾移植后甲状旁腺功能亢进症甲状旁腺切除术的时机。
Surgery. 2024 Dec;176(6):1617-1622. doi: 10.1016/j.surg.2024.08.010. Epub 2024 Sep 19.
本文引用的文献
1
Treatment of osteoporosis in the solid organ transplant recipient: an organ-based approach.实体器官移植受者骨质疏松症的治疗：基于器官的方法。
Ther Adv Endocrinol Metab. 2025 Jun 14;16:20420188251347351. doi: 10.1177/20420188251347351. eCollection 2025.
2
Hyperparathyroidism at 1 year after kidney transplantation is associated with graft loss.肾移植后 1 年内发生甲状旁腺功能亢进与移植物丢失有关。
Surgery. 2023 Jan;173(1):138-145. doi: 10.1016/j.surg.2022.07.031. Epub 2022 Oct 14.
3
A roadmap to parathyroidectomy for kidney transplant candidates.肾移植候选者甲状旁腺切除术路线图
Clin Kidney J. 2022 Feb 23;15(8):1459-1474. doi: 10.1093/ckj/sfac050. eCollection 2022 Aug.
4
The Influence of Parathyroidectomy on Osteoporotic Fractures in Kidney Transplant Recipients: Results from a Retrospective Single-Center Trial.甲状旁腺切除术对肾移植受者骨质疏松性骨折的影响：一项回顾性单中心试验的结果
J Clin Med. 2022 Jan 27;11(3):654. doi: 10.3390/jcm11030654.
5
Prevalence and risk factors for tertiary hyperparathyroidism in kidney transplant recipients.肾移植受者甲状旁腺功能亢进症的患病率及危险因素。
Surgery. 2022 Jan;171(1):69-76. doi: 10.1016/j.surg.2021.03.067. Epub 2021 Jul 12.
6
Long-term results of a randomized study comparing parathyroidectomy with cinacalcet for treating tertiary hyperparathyroidism.甲状旁腺切除术与西那卡塞治疗三发性甲状旁腺功能亢进症的随机研究的长期结果。
Clin Transplant. 2020 Aug;34(8):e13988. doi: 10.1111/ctr.13988. Epub 2020 Jun 3.
7
A Randomized Study Comparing Parathyroidectomy with Cinacalcet for Treating Hypercalcemia in Kidney Allograft Recipients with Hyperparathyroidism.一项比较甲状旁腺切除术与西那卡塞治疗肾移植受者甲状旁腺功能亢进所致高钙血症的随机研究。
J Am Soc Nephrol. 2016 Aug;27(8):2487-94. doi: 10.1681/ASN.2015060622. Epub 2015 Dec 8.
8
Persistent hyperparathyroidism is a major risk factor for fractures in the five years after kidney transplantation.移植肾五年后，持续性甲状旁腺功能亢进是骨折的一个主要危险因素。
Am J Transplant. 2013 Oct;13(10):2653-63. doi: 10.1111/ajt.12425. Epub 2013 Aug 26.
9
Cinacalcet improves bone density in post-kidney transplant hyperparathyroidism.西那卡塞可改善肾移植后甲状旁腺功能亢进患者的骨密度。
Transplant Proc. 2010 Nov;42(9):3554-8. doi: 10.1016/j.transproceed.2010.06.027.
Zotero 插件